<?xml version="1.0" encoding="UTF-8"?>
<p id="Par2">Worldwide, 14 million symptomatic infections, 5,200 stillbirths, and 300,000 deaths are attributed to hepatitis E virus (HEV) according to the World Health Organisation
 <sup>
  <xref ref-type="bibr" rid="CR1">1</xref>
 </sup>. While HEV infection is mostly associated with large epidemics in developing countries, autochthonous sporadic cases are on the rise in industrialised countries
 <sup>
  <xref ref-type="bibr" rid="CR2">2</xref>
 </sup>. In the UK, hepatitis E cases have been increasing since 2009, with an estimated annual infection rate of 200,000, which is largely attributed to the consumption of pork products
 <sup>
  <xref ref-type="bibr" rid="CR3">3</xref>,
  <xref ref-type="bibr" rid="CR4">4</xref>
 </sup>. Clinical symptoms of HEV are mainly associated with acute hepatitis, fulminant hepatic failure, or chronic hepatitis in immunocompromised patients and the elderly. HEV genotype 1 and 2 infection is associated with high mortality rates (up to 25%) in pregnant women
 <sup>
  <xref ref-type="bibr" rid="CR5">5</xref>,
  <xref ref-type="bibr" rid="CR6">6</xref>
 </sup>. Extra-hepatic lesions, including acute pancreatitis, renal failure, neurological diseases, haematological diseases, and the Guillainâ€“Barre syndrome, are linked with HEV infection, cases of which are increasing. However, its pathogenesis is not well understood
 <sup>
  <xref ref-type="bibr" rid="CR7">7</xref>
 </sup>. 
</p>
